Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kaishi, Kitamura"'
Autor:
Hiroyuki Suzuki, Kaishi Kitamura, Nohara Goto, Kenichiro Ishikawa, Tsunenori Ouchida, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8411 (2023)
Cluster of differentiation 44 (CD44) promotes tumor progression through the recruitment of growth factors and the acquisition of stemness, invasiveness, and drug resistance. CD44 has multiple isoforms including CD44 standard (CD44s) and CD44 variants
Externí odkaz:
https://doaj.org/article/7a5afe78ab0a42ba8ba724143f5a07ec
Autor:
Yu Isoda, Tomohiro Tanaka, Hiroyuki Suzuki, Teizo Asano, Kaishi Kitamura, Yuma Kudo, Ryo Ejima, Kazuki Ozawa, Takeo Yoshikawa, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42:73-76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcf8f7b276c942049e189abc430e8e20
https://doi.org/10.1089/mab.2022.0035
https://doi.org/10.1089/mab.2022.0035
Autor:
Yu Isoda, Tomohiro Tanaka, Hiroyuki Suzuki, Teizo Asano, Takeo Yoshikawa, Kaishi Kitamura, Yuma Kudo, Ryo Ejima, Kazuki Ozawa, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42:22-26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f801476313a3b3673ec34013df88254
https://doi.org/10.1089/mab.2022.0029
https://doi.org/10.1089/mab.2022.0029
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:133-141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d431fd6f4b9e55c7a9339537025e227
https://doi.org/10.1089/mab.2022.0010
https://doi.org/10.1089/mab.2022.0010
CC chemokine receptor 6 (CCR6) is a member of the G protein-coupled receptor (GPCR) family that is highly expressed in B lymphocytes, effector and memory T cells, regulatory T cells, and immature dendritic cells. CCR6 has been revealed to have import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec9ced45a693b833e0f9be1fabbb6fd8
https://doi.org/10.20944/preprints202303.0181.v1
https://doi.org/10.20944/preprints202303.0181.v1
Autor:
Hiroyuki Suzuki, Masaki Saito, Teizo Asano, Tomohiro Tanaka, Kaishi Kitamura, Yuma Kudo, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:110-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4b9b1250828b6e51035fa644ad1d968
https://doi.org/10.1089/mab.2022.0002
https://doi.org/10.1089/mab.2022.0002
Autor:
Yu, Isoda, Tomohiro, Tanaka, Hiroyuki, Suzuki, Teizo, Asano, Takeo, Yoshikawa, Kaishi, Kitamura, Yuma, Kudo, Ryo, Ejima, Kazuki, Ozawa, Mika K, Kaneko, Yukinari, Kato
Publikováno v:
Monoclonal antibodies in immunodiagnosis and immunotherapy.
An anti-mouse CXC chemokine receptor 6 (mCXCR6) monoclonal antibody (mAb), Cx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a13b128e987f6dcbf74528d73cce84ee
https://pubmed.ncbi.nlm.nih.gov/36383116
https://pubmed.ncbi.nlm.nih.gov/36383116
Publikováno v:
Monoclonal antibodies in immunodiagnosis and immunotherapy. 41(3)
The CXC chemokine receptor 6 (CXCR6) is a member of the G protein-coupled receptor family that is highly expressed in helper T type 1 cells, natural killer cells, cytotoxic T lymphocytes, and various type of cells in tumor microenvironment (TME). CXC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6d740f7a185c96857dfe289c3bc9316
https://pubmed.ncbi.nlm.nih.gov/35736626
https://pubmed.ncbi.nlm.nih.gov/35736626
Autor:
Hiroyuki, Suzuki, Masaki, Saito, Teizo, Asano, Tomohiro, Tanaka, Kaishi, Kitamura, Yuma, Kudo, Mika K, Kaneko, Yukinari, Kato
Publikováno v:
Monoclonal antibodies in immunodiagnosis and immunotherapy. 41(2)
The C-C motif chemokine receptor 8 (CCR8) is highly expressed in regulatory T cells. CCR8 is also expressed in many cancers and is associated with those progression. The development of monoclonal antibodies (mAbs) for CCR8 leads to cancer immunothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2bf92e2b9d4af0afb213b171a5be929e
https://pubmed.ncbi.nlm.nih.gov/35377236
https://pubmed.ncbi.nlm.nih.gov/35377236